BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Parker K, Mitra S, Thachil J. Is anticoagulating haemodialysis patients with non-valvular atrial fibrillation too risky? Br J Haematol 2018;181:725-36. [PMID: 29468649 DOI: 10.1111/bjh.15144] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Parker K, Thachil J. The use of direct oral anticoagulants in chronic kidney disease. Br J Haematol 2018;183:170-84. [PMID: 30183070 DOI: 10.1111/bjh.15564] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 3.8] [Reference Citation Analysis]
2 Swan D, Rocci A, Bradbury C, Thachil J. Venous thromboembolism in multiple myeloma - choice of prophylaxis, role of direct oral anticoagulants and special considerations. Br J Haematol 2018;183:538-56. [DOI: 10.1111/bjh.15684] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 5.0] [Reference Citation Analysis]
3 Parker K, Wong J. Is polypharmacy an increasing burden in chronic kidney disease? The German experience. Clin Kidney J 2019;12:659-62. [PMID: 31584570 DOI: 10.1093/ckj/sfz072] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]